secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K
Filed at:   2023-07-19T23:59:59+00:00
Accession:  0000950170-23-033516
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health raises ~$2.1M in public offering of 51.25M shares at $0.04/share
-----------------------------------------------------------------------------

- Offering of 51,250,000 shares priced at $0.040 per share, gross proceeds ~$2.1M.
- Net proceeds ~$1.9M after placement agent fees and expenses; intended for working capital.
- Maxim Group acted as placement agent, receiving 8% cash fee ($164,000) and 2,050,000 warrants.
- Placement agent warrants exercisable at $0.048/share for 5 years, 6-month lockout from closing.
- Officers and directors entered 30-day lock-up on company securities following closing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023033516/0000950170-23-033516-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017023033516/tivc-20230714.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-033516

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer